Showing results (261-270 of 277) with videos related to

Sort By:
Pageof 28
Seminars in Arthritis and Rheumatism|November 6, 2022
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trialL Hartman, M El Alili, M Cutolo, et al.
Annals of the Rheumatic Diseases|August 19, 2005
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial dataJ A P Da Silva, J W G Jacobs, J R Kirwan, et al.
Annals of the Rheumatic Diseases|July 23, 2013
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseasesN Duru, M C van der Goes, J W G Jacobs, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupJ Avouac, J Fransen, U A Walker, et al.
Annals of the Rheumatic Diseases|August 14, 2009
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategyM Matucci-Cerinic, Y Allanore, L Czirják, et al.
Reumatismo|January 22, 2011
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritisM Fabris, L Quartuccio, S Lombardi, et al.
Annals of the Rheumatic Diseases|August 10, 2010
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practiceM C van der Goes, J W G Jacobs, M Boers, et al.
Clinical and Experimental Rheumatology|September 3, 2010
Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA StudyD Jawaheer, J Olsen, M Lahiff, et al.
Annals of the Rheumatic Diseases|July 31, 2007
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesJ N Hoes, J W G Jacobs, M Boers, et al.
Annals of the Rheumatic Diseases|September 19, 2009
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesM C van der Goes, J W G Jacobs, M Boers, et al.
Pageof 28